News & Updates
Filter by Specialty:

Add-on immunotherapy prolongs survival in advanced endometrial cancer
In the treatment of patients with advanced or recurrent endometrial carcinoma, adding the PD-L1 inhibitor atezolizumab to chemotherapy helps lower the risk of progression or death, according to the phase III AtTEnd trial.
Add-on immunotherapy prolongs survival in advanced endometrial cancer
03 Nov 2023
Remnant cholesterol ups GDM risk in pregnant women
Increased levels of remnant cholesterol (RC) appear to elevate the risk of gestational diabetes mellitus (GDM), independent of traditional risk factors, suggests a study. Moreover, pregnant women with high prepregnancy body mass index (BMI), high triglyceride (TG), and high RC levels are at greater GDM risk.
Remnant cholesterol ups GDM risk in pregnant women
29 Oct 2023
Pooled EAGLE subgroup analyses boost gepotidacin potential for uUTI in females
In a pooled analyses of data from the EAGLE*-2 and EAGLE-3 studies, the investigational, first-in-class, oral, triazaacenaphthylene bactericidal antibiotic gepotidacin showed consistent therapeutic efficacy across key patient subgroups and had an acceptable safety profile in female adults and adolescents with uncomplicated urinary tract infections (uUTI) compared with nitrofurantoin.
Pooled EAGLE subgroup analyses boost gepotidacin potential for uUTI in females
25 Oct 2023
Postpartum depression more common in pregnant women with rheumatic disease
Women of reproductive age with axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), or rheumatoid arthritis (RA) are more likely to experience postpartum depression than those without any rheumatic disease (RD), according to a study.